(19)
(11) EP 4 347 655 A1

(12)

(43) Date of publication:
10.04.2024 Bulletin 2024/15

(21) Application number: 22736093.0

(22) Date of filing: 02.06.2022
(51) International Patent Classification (IPC): 
C07K 16/28(2006.01)
A61K 39/00(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/2866; C07K 2317/34; C07K 2317/732; C07K 2317/41; C07K 2317/73; C07K 2317/92; C07K 2317/569; C07K 16/2818; C07K 16/28; A61K 2039/507
(86) International application number:
PCT/US2022/032011
(87) International publication number:
WO 2022/256563 (08.12.2022 Gazette 2022/49)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 04.06.2021 US 202163197271 P
24.08.2021 US 202163236551 P

(71) Applicants:
  • Amgen Inc.
    Thousand Oaks, California 91320 (US)
  • Amgen Research (Munich) GmbH
    81477 München (DE)

(72) Inventors:
  • PIERCE, Nathan William
    Thousand Oaks, California 91320-1799 (US)
  • KIELCZEWSKA, Agnieszka
    Thousand Oaks, California 91320-1799 (US)
  • CHEN, Wentao
    Thousand Oaks, California 91320-1799 (US)
  • NOLAN-STEVAUX, Olivier
    Thousand Oaks, California 91320-1799 (US)
  • BATES, Darren L.
    Thousand Oaks, California 91320-1799 (US)
  • WINKEL, Lisa
    81477 Munich (DE)
  • DAHLHOFF, Christoph
    81477 Munich (DE)
  • RAUM, Tobias
    81477 Munich (DE)
  • BLUEMEL, Claudia
    81477 Munich (DE)
  • HONER, Jonas Karl-Josef
    81477 Munich (DE)

(74) Representative: Lau, Sarah Jane et al
Kilburn & Strode LLP Lacon London 84 Theobalds Road
London WC1X 8NL
London WC1X 8NL (GB)

   


(54) ANTI-CCR8 ANTIBODIES AND USES THEREOF